Prognostic factors of patients with recurrent uterine malignancies undergoing secondary cytoreductive surgery
Abstract Background Several studies have demonstrated that secondary cytoreductive surgery (SCS) for patients with recurrent uterine malignancies may improve the survival. However, the selection criteria for SCS remain to be defined. This study aimed to assess the outcome of SCS and to explore facto...
Saved in:
Main Authors: | Chenyan Fang (Author), Yingli Zhang (Author), Ping Zhang (Author), Tao Zhu (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2024-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Cytoreduction can reduce the recurrence rate of patients with occult uterine sarcoma undergoing morcellation: a retrospective study
by: Chao Ding, et al.
Published: (2022) -
Changes in peripheral lymphocyte populations in patients with advanced/recurrent ovarian cancer undergoing splenectomy during cytoreductive surgery
by: Wei Chen, et al.
Published: (2021) -
Primary cytoreductive surgery or interval cytoreductive surgery
by: Yiu-Tai Li, et al.
Published: (2024) -
Interval between secondary cytoreductive surgery and adjuvant chemotherapy is not associated with survivals in patients with recurrent ovarian cancer
by: Soo Young Jeong, et al.
Published: (2019) -
The survival outcome and complication of secondary cytoreductive surgery plus chemotherapy in recurrent ovarian cancer: a systematic review and meta-analysis
by: Ting Ding, et al.
Published: (2021)